Completed PHASE4 INTERVENTIONAL 3-arm NCT00978575

Iron Substitution After Upper Gastro-Intestinal Bleeding

Comparison of the Efficacy of Compliant Oral Iron Treatment (FerroDuretter ®) for 3 Months After Discharge Versus Single-dose of Intravenous Iron (Ferinject ®) Before Discharge in Patients With Acute Bleeding From Upper Gastrointestinal Tract. A Double Blinded Randomized Trial

Sponsor: GCP-unit at Aarhus University Hospital, Aarhus, Denmark

Conditions Anemia Gastrointestinal Hemorrhage

Interventions Ferrosulfate Placebo ferricarboxymaltose

Updated 6 times since 2017 Last updated: Apr 4, 2013 Started: Apr 30, 2010 Primary completion: Jan 31, 2013 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00978575, this PHASE4 trial focuses on Anemia and Gastrointestinal Hemorrhage and remains completed. Sponsored by GCP-unit at Aarhus University Hospital, Aarhus, Denmark, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE4
Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GCP-unit at Aarhus University Hospital, Aarhus, Denmark
University of Aarhus
Vifor Pharma

Data source: University of Aarhus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aarhus, Denmark